NCT00890097View on ClinicalTrials.gov

Geographic Atrophy Treatment Evaluation

PHASE3TerminatedINTERVENTIONAL

Enrollment

772

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Geographic AtrophyAge-Related Macular Degeneration

Interventions

DRUG

AL-8309B Ophthalmic Solution

DRUG

AL-8309B Vehicle

Inactive ingredients used as placebo comparator

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY